HMGCR and cancer: Statins reduce blood cholesterol levels by inhibiting the rate-limiting enzyme of the mevalonate pathway, hydroxymethylglutaryl-CoA reductase (HMGCR), and statin use in patients with various cancer types has been associated with reduced mortality4.